| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2131.47 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1593.07 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 1441.46 | 97 |
| GSM780719 | Untreated after 4 days (C1_2) | 2358.89 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1591.92 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 1413.48 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1356.3 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2149.67 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2042.44 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1418.87 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2334 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2157.29 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2352.31 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1888.4 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2361.12 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 2471.62 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1784.49 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2163.08 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2731.26 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2545.32 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1797.71 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2598.72 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2151.7 | 98 |